Caplin Point Laboratories Limited
Caplin Point Laboratories Limited Fundamental Analysis
Caplin Point Laboratories Limited (CAPLIPOINT.NS) shows strong financial fundamentals with a PE ratio of 21.39, profit margin of 29.34%, and ROE of 21.40%. The company generates $20.9B in annual revenue with strong year-over-year growth of 14.35%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 79.3/100 based on profitability, valuation, growth, and balance sheet metrics. The B grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze CAPLIPOINT.NS's fundamental strength across five key dimensions:
Efficiency Score
ExcellentCAPLIPOINT.NS demonstrates superior asset utilization.
Valuation Score
ModerateCAPLIPOINT.NS shows balanced valuation metrics.
Growth Score
ExcellentCAPLIPOINT.NS delivers strong and consistent growth momentum.
Financial Health Score
ExcellentCAPLIPOINT.NS maintains a strong and stable balance sheet.
Profitability Score
ModerateCAPLIPOINT.NS maintains healthy but balanced margins.
Key Financial Metrics
Is CAPLIPOINT.NS Expensive or Cheap?
P/E Ratio
CAPLIPOINT.NS trades at 21.39 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, CAPLIPOINT.NS's PEG of 5.05 indicates potential overvaluation.
Price to Book
The market values Caplin Point Laboratories Limited at 4.16 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 17.35 times EBITDA. This signals the market has high growth expectations.
How Well Does CAPLIPOINT.NS Make Money?
Net Profit Margin
For every $100 in sales, Caplin Point Laboratories Limited keeps $29.34 as profit after all expenses.
Operating Margin
Core operations generate 38.31 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $21.40 in profit for every $100 of shareholder equity.
ROA
Caplin Point Laboratories Limited generates $17.51 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Caplin Point Laboratories Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Caplin Point Laboratories Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
CAPLIPOINT.NS converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
21.39
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
5.05
vs 25 benchmark
P/B Ratio
Price to book value ratio
4.16
vs 25 benchmark
P/S Ratio
Price to sales ratio
6.28
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.003
vs 25 benchmark
Current Ratio
Current assets to current liabilities
8.17
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.21
vs 25 benchmark
ROA
Return on assets percentage
0.18
vs 25 benchmark
ROCE
Return on capital employed
0.25
vs 25 benchmark
How CAPLIPOINT.NS Stacks Against Its Sector Peers
| Metric | CAPLIPOINT.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 21.39 | 29.45 | Better (Cheaper) |
| ROE | 21.40% | 779.00% | Weak |
| Net Margin | 29.34% | -24936.00% (disorted) | Strong |
| Debt/Equity | 0.00 | 0.26 | Strong (Low Leverage) |
| Current Ratio | 8.17 | 4.65 | Strong Liquidity |
| ROA | 17.51% | -19344.00% (disorted) | Strong |
CAPLIPOINT.NS outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Caplin Point Laboratories Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
124.21%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
149.11%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
866.51%
Industry Style: Defensive, Growth, Innovation
High Growth